Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Imaging, Diagnosis, Prognosis

Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype

Inna Serganova, Asif Rizwan, Xiaohui Ni, Sunitha B. Thakur, Jelena Vider, James Russell, Ronald Blasberg and Jason A. Koutcher
Inna Serganova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asif Rizwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohui Ni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunitha B. Thakur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jelena Vider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Russell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Blasberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason A. Koutcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-11-0397 Published October 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Metabolic features of isogenic 67NR and 4T1 breast cancer cells. A, LDH-A mRNA expression in 67NR and 4T1 cells by the semiquantitative RT-PCR. B, LDH-A, HXKII, and PKM2 proteins expression assessed by Western blotting. C, total LDH enzyme activity in 67NR cells and 4T1 cells. D, cell culture medium acidification; supernatant pH. E, oxygen consumption of 67NR and 4T1 cells in normal growth media [Dulbecco's Modified Eagle's Media (DMEM; high glucose) + 10% fetal calf serum + 2 mmol/L l-glutamine, 25 mmol/L HEPES] and upon treatment with 1 μmol/L of rotenone using the OxyLite system. F, glucose utilization; clearance of glucose from the culture medium. G, lactate production; appearance of lactate in the culture medium.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Lactate CSI spectra. A, different sizes of 67NR nonmetastatic tumors are shown. B, 4T1 metastasis-prone tumors are shown. Lactate signal was detected using CSI and a SelMQC editing sequence. C, LDH-A protein expression was assessed by Western blotting in different sizes of 67NR and 4T1 tumors. TV, tumor volume.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    MRSI measurements of lactate concentration in orthotopic 67NR and 4T1 breast tumors during tumor growth. Lactate concentration in (A) 67NR tumors (solid circles, dashed line) and in (B) 4T1 tumors (solid squares, solid line) plotted versus tumor volume. C, average lactate concentration at 3 different tumor volumes (small, <150 mm3; medium, 150–400 mm3; and large, >400 mm3). Values are the mean ± SD. *, P < 0.05; **, P < 0.01. D, tumor lactate concentration plotted versus days postorthotopic implantation.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    FDG-PET measurements of [18F]FDG accumulation in orthotopic 67NR and 4T1 breast tumors during tumor growth. [18F]FDG accumulation in (A) 67NR tumors (solid circles, dashed line) and in (B) 4T1 tumors (solid squares, solid line) plotted versus tumor volume. C, average [18F]FDG accumulation at 3 different tumor volumes (small, <150 mm3; medium, 150–400 mm3; and large, >400 mm3). Values are the mean ± SD. D, representative [18F]FDG microPET images of tumor-bearing mice; small and large 4T1 orthotopic tumors are visualized (white arrows). High radioactivity is seen in the cervical brown fat, heart, and bladder. Values are color coded to a range of values (%ID/mL).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    The effect of hypoxia on the cell growth and LDH-A expression. A, growth profiles of 67NR cells and 4T1 cells under normoxic (N, 21%) and hypoxic (H, 1%) conditions. B, immunoblot analysis of LDH-A and LDH-B subunits from 67NR and 4T1 cells exposed to normoxia and hypoxia for 24 hours. C, the β-actin–normalized intensity of LDH-A and LDH-B levels in cells under normoxic and hypoxic conditions. D, the ratio of β-actin–normalized LDH-A and LDH-B expression under normoxic and hypoxic conditions.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Immunohistochemical staining of 67NR and 4T1 tumors. Histology (H&E), endothelial cell density (CD31, red), blood flow (Hoechst 33342, blue), and hypoxia (Pimonidazole, green) are compared. Small 67NR tumors showed no necrosis, a uniform endothelial cell density and blood flow, and no hypoxia. Medium-size 67NR tumors showed some pimonidazole staining. This small 4T1 tumor shows some central necrosis, a decrease in endothelial cell density, and blood flow, with a corresponding zone of hypoxia surrounding the necrotic zone. These observations were amplified in medium-size 4T1 tumors.

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Figure 1 - PDF file - 442K
    • Supplementary Figure 2 - PDF file - 192K
    • Supplementary Figure 3 - PDF file - 790K
    • Supplementary Figure 4 - PDF file - 1.05MB
    • Supplementary Figure 5 - PDF file - 326K
PreviousNext
Back to top
Clinical Cancer Research: 17 (19)
October 2011
Volume 17, Issue 19
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype
Inna Serganova, Asif Rizwan, Xiaohui Ni, Sunitha B. Thakur, Jelena Vider, James Russell, Ronald Blasberg and Jason A. Koutcher
Clin Cancer Res October 1 2011 (17) (19) 6250-6261; DOI: 10.1158/1078-0432.CCR-11-0397

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype
Inna Serganova, Asif Rizwan, Xiaohui Ni, Sunitha B. Thakur, Jelena Vider, James Russell, Ronald Blasberg and Jason A. Koutcher
Clin Cancer Res October 1 2011 (17) (19) 6250-6261; DOI: 10.1158/1078-0432.CCR-11-0397
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • In vivo Fluorescence Lifetime Imaging for Monitoring the Cancer Treatment
  • Variability in Assessing Response in Metastatic Colorectal Cancer
  • 18FDG PET-MRI of Breast Tumors: Feasibility
Show more Imaging, Diagnosis, Prognosis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement